Biovail Announces Appointment Of Bruce D. Brydon As President And Chief Executive Officer
TORONTO, Canada–(BUSINESS WIRE)–Jan. 13, 1995–Biovail Corporation International (AMEX:TSE:BVF) today announced the appointment of Bruce D. Brydon as President and Chief Executive Officer of the Company. Eugene Melnyk, Chairman of the Board, who previously held all three positions, noted that today’s appointment expands the depth of executive management at Biovail.
Mr. Brydon, 48, joins the Company from the prestigious multi- national Boehringer Mannheim where he served as President, Managing Director and Chairman of the Board of the Canadian division. Prior to his leadership position at Boehringer Mannheim, Mr. Brydon was the President and Chief Executive Officer of Beiersdorf Canada Inc.
Mr. Brydon’s relevant and in-depth career experience spans the key areas of Diagnostic Medicine, Pharmaceuticals, Clinical Research and Molecular Biochemicals.
Eugene Melnyk, Chairman of the Board, commented, “We are excited about the talent and expertise that Bruce will contribute to our future growth. Bruce’s wealth of experience in the health care industry, spanning more than 20 years, will make a significant impact as we enter the next phase of the Company’s development.
Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical evaluation, registration and manufacturing of drug products utilizing advanced drug delivery technologies.
CONTACT: Biovail Corporation International
APPROVED BY: Eugene Melnyk
Chairman of the Board
Lisa Carlton/Courtney Kraft
COPYRIGHT 1995 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning